These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 1659902)
21. Increased late rejection in cytomegalovirus-immunoglobulin-M-positive heart transplantation patients. Bunke M; Ganzel B; Gardner C Transplant Proc; 1995 Oct; 27(5 Suppl 1):44-5. PubMed ID: 7482819 [No Abstract] [Full Text] [Related]
22. Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation. Sarmiento E; Rodríguez-Molina J; Muñoz P; Fernández-Yánez J; Palomo J; Fogueda M; Fernández-Cruz E; Bouza E; Carbone J Transplant Proc; 2005 Nov; 37(9):4046-9. PubMed ID: 16386623 [TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact. Gray J; Wreghitt TG; Pavel P; Smyth RL; Parameshwar J; Stewart S; Cary N; Large S; Wallwork J J Heart Lung Transplant; 1995; 14(4):640-6. PubMed ID: 7578169 [TBL] [Abstract][Full Text] [Related]
24. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples. Dangel V; Bäder U; Enders G J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547 [TBL] [Abstract][Full Text] [Related]
25. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. Aalto SM; Linnavuori K; Peltola H; Vuori E; Weissbrich B; Schubert J; Hedman L; Hedman K J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683 [TBL] [Abstract][Full Text] [Related]
26. The transplanted kidney as a source of cytomegalovirus infection. Ho M; Suwansirikul S; Dowling JN; Youngblood LA; Armstrong JA N Engl J Med; 1975 Nov; 293(22):1109-12. PubMed ID: 171567 [TBL] [Abstract][Full Text] [Related]
27. [Performance of the IgG avidity test in patients with cytomegalovirus disease]. Lafarga B; Noguera FJ; Bolanos M; Pérez MC; Rodríguez H Enferm Infecc Microbiol Clin; 1997 Apr; 15(4):190-5. PubMed ID: 9312277 [TBL] [Abstract][Full Text] [Related]
28. A new C1q solid-phase assay for the detection of IgM immune complexes: application to the follow-up of kidney graft recipients with recurrent cytomegalovirus infection. Basson J; Tardy JC; Aymard M J Clin Lab Immunol; 1990 Jan; 31(1):43-9. PubMed ID: 1966984 [TBL] [Abstract][Full Text] [Related]
29. Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients. Kamar N; Mengelle C; Yahyaoui S; Sandres-Sauné K; Durand D; Izopet J; Rostaing L J Clin Virol; 2005 May; 33(1):35-42. PubMed ID: 15797363 [TBL] [Abstract][Full Text] [Related]
30. No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group. Ruutu T; Ljungman P; Brinch L; Lenhoff S; Lönnqvist B; Ringdén O; Ruutu P; Volin L; Albrechtsen D; Sallerfors B; Ebeling F; Myllylä G Bone Marrow Transplant; 1997 Feb; 19(3):233-6. PubMed ID: 9028551 [TBL] [Abstract][Full Text] [Related]
31. What are the implications of cardiac infection with cytomegalovirus before heart transplantation? Lowry RW; Adam E; Hu C; Kleiman NS; Cocanougher B; Windsor N; Bitar JN; Melnick JL; Young JB J Heart Lung Transplant; 1994; 13(1 Pt 1):122-8. PubMed ID: 8167117 [TBL] [Abstract][Full Text] [Related]
32. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies. Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173 [TBL] [Abstract][Full Text] [Related]
33. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection. Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650 [TBL] [Abstract][Full Text] [Related]
34. Should heart-lung transplant donors and recipients be matched according to cytomegalovirus serologic status? Novick RJ; Menkis AH; McKenzie FN; Reid KR; Ahmad D J Heart Transplant; 1990; 9(6):699-706. PubMed ID: 2177496 [TBL] [Abstract][Full Text] [Related]
35. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971 [TBL] [Abstract][Full Text] [Related]
36. Late onset of fatal cytomegalovirus infection after renal transplantation. Primary or reactivation infection? Linnemann CC; Dunn CR; First MR; Alvira M; Schiff GM Arch Intern Med; 1978 Aug; 138(8):1247-50. PubMed ID: 209756 [TBL] [Abstract][Full Text] [Related]
37. [Frequency of infection with cytomegaloviruses (CMV) following kidney transplantation and initial experiences with CMV gamma globulin prevention]. Kaden J; Scholz D; Eichler C; May G Immun Infekt; 1985 Nov; 13(6):290-5. PubMed ID: 3000922 [TBL] [Abstract][Full Text] [Related]
38. Laboratory evaluation of the new Access ® cytomegalovirus immunoglobulin IgM and IgG assays. Carlier P; Harika N; Bailly R; Vranken G J Clin Virol; 2010 Nov; 49(3):192-7. PubMed ID: 20801078 [TBL] [Abstract][Full Text] [Related]
39. Comparison of five CMV IgM immunoassays with CMV IgG avidity for diagnosis of primary CMV infection. BaAlawi F; Robertson PW; Lahra M; Rawlinson WD Pathology; 2012 Jun; 44(4):381-3. PubMed ID: 22531352 [No Abstract] [Full Text] [Related]
40. [Cytomegalovirus infection and coronary sclerosis after heart transplantation]. Loebe M; Schüler S; Spiegelsberger S; Warnecke H; Fleck E; Hetzer R Dtsch Med Wochenschr; 1990 Aug; 115(34):1266-9. PubMed ID: 2167829 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]